Markets:

Overview

News

Currencies

International

Treasuries

Celldex Therapeutics, Inc. - Common Stock (NQ:CLDX)

34.15 -0.10 (-0.29%)

Streaming Delayed Price Updated: 11:31 AM EDT, Apr 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Celldex Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

38 Stocks Moving In Monday's Mid-Day Session ↗

July 12, 2021

Gainers State Auto Financial Corporation (NASDAQ: STFC) shares jumped 189.5% to $49.96 after the company agreed to be acquired by Liberty Mutual Insurance for $52 per share in...

Via Benzinga

Why Celldex Therapeutics Stock Is Skyrocketing Today ↗

July 12, 2021

Investors liked Celldex's early stage clinical results.

Via The Motley Fool

Celldex Therapeutics Stock Rocketed Above A Profit-Taking Zone — Here's Why ↗

July 12, 2021

Celldex Therapeutics unveiled bullish test results for its hives treatment on Friday, and CLDX stock flew to a three-year high on Monday.

Via Investor's Business Daily

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 12, 2021

Gainers Celldex Therapeutics (NASDAQ:CLDX) stock rose 41.93% to $46.0 during Monday's pre-market session. The company's market cap stands at $1.8 billion. 180 Life...

Via Benzinga

10 Biggest Price Target Changes For Monday ↗

July 12, 2021

RBC Capital boosted Chipotle Mexican Grill, Inc. (NYSE:C...

Via Benzinga

24 Stocks Moving in Monday's Pre-Market Session ↗

July 12, 2021

Gainers SGOCO Group, Ltd. (NASDAQ: SGOC) shares rose 67.7% to $16.42 in pre-market trading after jumping around 280% on Friday. MER Telemanagement Solutions Ltd. (NASDAQ: MTSL)...

Via Benzinga

Celldex Stock Surges As It Touts Early-Stage Skin Disease Study Win For CDX-0159 ↗

July 12, 2021

Celldex Therapeutics Inc (NASDAQ: CLDX) got a boost Friday with a data readout from Phase 1b trial of CDX-0159 in patients with antihistamine refractory cold...

Via Benzinga

The Most Volatile Stocks on Earnings — July 2021 ↗

July 09, 2021

The Q2 2021 earnings reporting period starts up next week with five of the six major banks reporting their quarterly numbers.

Via Talk Markets

Top Picks Mid-Year Updates- Celldex Therapeutics ↗

July 04, 2021

Celldex Therapeutics (CLDX) remains one of our Top Picks for 2021 with the company delivering value creating data updates so far this year. The stock has risen 53% so far this year.

Via Talk Markets

The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs ↗

June 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 29) 10x Genomics, Inc. (NASDAQ...

Via Benzinga

Could Celldex Be a Millionaire-Maker Stock? ↗

April 10, 2021

Not at its present valuation, it's not.

Via The Motley Fool

Stocks That Hit 52-Week Highs On Tuesday ↗

June 29, 2021

Tuesday's morning session saw 105 companies set new 52-week highs. Things to Consider: The largest company by market cap to break to a new 52-week high was...

Via Benzinga

The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout ↗

June 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 28) Alexion Pharmaceuticals,...

Via Benzinga

The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs ↗

April 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29) AtriCure, Inc. (NASDAQ:...

Via Benzinga

The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx ↗

April 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:...

Via Benzinga

The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping ↗

April 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.